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Brief CommunicationsThe third-generation Medtronic Mosaic porcine biopros-
thesis (Medtronic Inc, Minneapolis, Minn) was introduced
in 1994. The valve leaflets are fixed in glutaraldehyde at
zero pressure (applying equal pressure to the inflow and out-
flow ends of the valve), the root is dilated to a pressure of 40
mm Hg (‘‘physiologic fixation’’), the fixed tissue is treated
with a-aminooleic acid (a long-chain fatty acid that binds
to the aldehyde fractions of the glutaraldehyde-preserved
porcine tissue) to reduce calcification, and the tissue is
mounted on a Hancock II (Medtronic Inc) flexible stent
made of acetyl copolymer covered with Dacron fabric.1,2
CLINICAL SUMMARY
The Medtronic Mosaic porcine valve has been reported to
be both reliable and durable over time.1-4 The alarmingly
early stenosis of an implanted Medtronic Mosaic porcine
valve (Medtronic) necessitating its replacement prompted
a review of the Medtronic Mosaic valves implanted in pa-
tients at the Washington University School of Medicine.
Approval from the Washington University Human
Research Protection Office was obtained to perform this
review. Patients with valvular stenosis with endocarditis
(N ¼ 1) or end-stage renal disease (N ¼ 1) were excluded.
RESULTS
Between August 17, 2001, and December 5, 2005, 122
Medtronic Mosaic valves were implanted in patients at the
Washington University School of Medicine in the aortic
(106), mitral (6), tricuspid (9), or both aortic and mitral (1)
positions. Four of 106 patients with valves implanted in
the aortic position were found to have early (3–44 months)
development of severe stenosis necessitating replacement.
Table 1 summarizes the patient information for the 4 patients
described. Figure 1 depicts valves explanted from patients B
and D. These valves have the strikingly similar appearance
of thickened material resulting in immobility of the leaflets.
Of note, they were implanted by 2 different surgeons.
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Early (2-year follow-up) results after implantation of
the Medtronic Mosaic porcine valve reported appropriate
valve function and no primary structural valve failure.1
Follow-up at 6 years by Jamieson and colleagues3 docu-
mented 4 cases of structural valve deterioration (2 aortic
and 2 mitral) after the implantation of 657 Medtronic
Mosaic porcine valves. However, no patients aged more
than 60 years had aortic structural valve deterioration
in this review. Freedom from structural valve deteriora-
tion in the aortic position at 8.5 years has been reported
FIGURE 1. A,MedtronicMosaic (Medtronic Inc,Minneapolis,Minn) por-
cine aortic valve explanted after 14 months from patient B after significant
stenosis was diagnosed. B,MedtronicMosaic porcine aortic valve explanted
after 3 months from patient D after significant stenosis was diagnosed.rgery c June 2009
Brief CommunicationsTABLE 1. Clinical data in 4 patients in whom early (3–44 months) valvular stenosis developed
Patient
Year of
implant
Implant
position
and size
Indexed effective
orifice area
(EOA/BSA in cm2/m2)
Indication for
explantation
(aortic valve
gradients in mm Hg)
Months
implanted
Age at redo
operation (y) Operative findings
A 2002 Aortic, 23 mm 1.51/1.81 ¼ 0.83 Aortic stenosis (AVA 1.0
cm2), peak 44, mean 26
44 76 Thickened leaflets,
small perforation 1 leaflet
B 2003 Aortic, 23 mm 1.51/1.99 ¼ 0.76 Aortic stenosis (AVA 0.7
cm2), peak 88, mean 45
14 74 Thickened leaflets
(Figure 1, A)
C 2004 Aortic, 23 mm 1.51/1.83 ¼ 0.83 Aortic stenosis (AVA 0.7
cm2), peak 100,
mean 60
19 70 Thickened leaflets,
pannus
D 2007 Aortic, 25 mm 1.69/1.90 ¼ 0.89 Aortic stenosis, peak 65,
mean 42
3 73 Thickened leaflets, pannus
(Figure 1, B)
AVA, Aortic valve area; BSA, body surface area; EOA, effective orifice area.to be 97.4% by Botzenhardt and colleagues4 and 87.1%
at 10 years by Riess and colleagues.2 In the review by
Riess and colleagues, there was no structural valvular de-
terioration at 10 years in patients aged more than 65
years.2
Improved valve durability in patients aged more than 65
years in reported studies2,3 was not seen in our patients.
All 4 patients were aged more than 68 years at the time of
implant, and all were aged 70 years or more at the time of
the redo operation.
Patient–prosthesis mismatch was excluded as a cause of
early stenosis because the indexed effective orifice area
was greater than 0.75 cm2/m2 in all 4 patients. Explanted
valves were examined by a pathologist at the Washington
University School of Medicine and by a pathologist after re-
turn of the valves to Medtronic Inc, and no cause for the ste-
nosis could be determined in any case. The cause of earlyTricuspid valve regurgitation after h
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The Journal of Thoracic and Cvalvular stenosis, whether it is related to patient factors or
valve factors, remains unclear.
CONCLUSIONS
Continued close and long-term follow-up of patients re-
ceiving the Medtronic Mosaic porcine valve is imperative.
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Tricuspid valve regurgitation (TR) after orthotopic heart
transplantation (OHT) is of concern owing to its correlation
with right ventricular dysfunction and mortality.1
Studies show that the bicaval anastomosis technique
decreases the incidence TR when compared with biatrial
techniques.2 More recent studies show that modified surgi-
cal techniques, such as tricuspid valve annuloplasty or
a modified inferior vena cava anastomosis, may alleviate
moderate and severe TR after transplantation.3,4
This study examines the long-term natural history of TR
after OHT.
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